NCT04412148Unknown4 期
Modified SALT Score for Assessment of Alopecia Areata
Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年1月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Percentage involvement
研究概览
简要总结
Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •localized scalp AA ( 2 patches and ≤50% scalp involvement , duration more than 6 months) • patients who did not receive any medication for at least 2 months before starting the study and those who agreed to join the study and signed written consent.
排除标准
- •• pregnant, and lactating females
- •Alopecia totalis or universalis or ophiasis or cicatritial alopecia
- •Usage of systemic treatment of alopecia areata 2 months prior to the study.
- •Any scalp lesion within the treated area
- •Bleeding diathesis, severe anemia or platelet disorders
- •Medical conditions such as autoimmune diseases.
研究组 & 干预措施
Intralesional Steroids
Active Comparator
干预措施: Triamcinolone Acetonide (Drug)
Control
Placebo Comparator
干预措施: saline (Other)
结局指标
主要结局
Percentage involvement
时间窗: 6months to 1 year
Degree of severity expressed as a percentage
Modified Severity of Alopecia Tool (mSALT) score
时间窗: 6 months to 1 year
New Score calculating severity (hair density) and area as a number minimum value is 0 and maximum value is 105 the higher the number of the score the worse the affection
次要结局
未报告次要终点
研究者
Rana F Hilal, MD
Principal Investigator
Kasr El Aini Hospital
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia AreataAlopecia AreataNCT01246284University of British Columbia5
已完成
2 期
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia AreataAlopecia AreataNCT00484679University of Minnesota18
已完成
4 期
Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia AreataAlopecia AreataNCT02350023Post Graduate Institute of Medical Education and Research, Chandigarh50
招募中
不适用
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia AreataAlopecia AreataNCT06564805Universidad Autonoma de Nuevo Leon30
已完成
不适用
New Treatment of Alopecia AreataAlopecia AreataNCT05594316Al-Azhar University40